Insider Trading History of Goldsmith Bruce A

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Goldsmith Bruce A since 2011. This trader's CIK number is 1500322. At the time of last reporting, Goldsmith Bruce A was the CEO and President of Passage Bio, Inc.. (stock ticker symbol PASG). Also see all insider trading activities at Passage Bio, Inc..

Note that in the past Goldsmith Bruce A also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Passage Bio, Inc. (PASG) by Goldsmith Bruce A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 PASG 10,000 $31,500 0 $0 0 $0
2021 PASG 2,000 $26,230 0 $0 0 $0
2020 PASG 1,100 $19,800 0 $0 0 $0

Yearly summary of insider trading at Allos Therapeutics Inc (ALTH) by Goldsmith Bruce A

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 ALTH 0 $0 12,053 $18,406 0 $0
2011 ALTH 0 $0 12,765 $18,440 0 $0


Insider trading activities at 2 companies by Goldsmith Bruce A:

1. Passage Bio, Inc. (PASG)

2. Allos Therapeutics Inc (ALTH)

Table 1. Insider trading of Passage Bio, Inc. (PASG) by Goldsmith Bruce A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-21 PASG Buy 10,000 3.15 31,500
2021-05-21 PASG Buy 2,000 13.12 26,230
2020-03-03 PASG Buy 1,100 18.00 19,800

Table 2. Insider trading of Allos Therapeutics Inc (ALTH) by Goldsmith Bruce A

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-03-01 ALTH Sale 4,473 1.50 6,691
2012-02-29 ALTH Sale 4,505 1.52 6,870
2012-02-24 ALTH Sale 575 1.54 888
2012-02-23 ALTH Sale 2,500 1.58 3,957
2011-11-16 ALTH Sale 300 1.43 429
2011-11-15 ALTH Sale 12,465 1.45 18,011

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldsmith Bruce A (CEO and President of Passage Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.